The outer segment of the vertebrate rod photoreceptor is a highly modified cilium composed of many discrete membranous discs that are filled with the protein machinery necessary for phototransduction. The unique outer segment structure is renewed daily with growth at the base of the outer segment where new discs are formed and shedding at the distal end where old discs are phagocytized by the retinal pigment epithelium. In order to understand how outer segment renewal is regulated to maintain outer segment length and function, we used a small molecule screening approach with the transgenic (hsp70:HA-mCherry TM ) zebrafish, which expresses a genetically-encoded marker of outer segment renewal. We identified compounds with known bioactivity that affect five content areas: outer segment growth, outer segment shedding, clearance of shed outer segment tips, Rhodopsin mislocalization, and differentiation at the ciliary marginal zone. Signaling pathways that are targeted by the identified compounds include cyclooxygenase in outer segment growth, γ-Secretase in outer segment shedding, and mTor in RPE phagocytosis. The data generated by this screen provides a foundation for further investigation of the signaling pathways that regulate photoreceptor outer segment renewal.
Vertebrate photoreceptors are specialized light-sensing neurons with unique morphology that is essential for function. The compartmentalized structure includes a highly modified cilium called the outer segment, which contains densely stacked membranous discs. These discs are packed with the phototransduction machinery that absorbs and converts light into the membrane potential change that alters neurotransmitter release. Blinding diseases such as retinitis pigmentosa and macular degeneration are characterized by degeneration and loss of photoreceptors 1, 2 . Therefore, a better understanding of the cellular maintenance of the photoreceptor outer segment may provide guidance for the design and optimization of treatments to prevent vision loss and restore or prolong vision.
The rod photoreceptor outer segment (ROS) contains on the order of 1,000 discrete discs that are stacked perpendicularly to the ciliary axoneme 3 . In order to supply the ROS with fresh membrane and protein, the ROS undergoes a unique process of continuous renewal. Using autoradiography to detect pulse-labeled H 3 -proteins, it was observed that new protein-packed discs are regularly added to the base of the ROS 4, 5 . Recent studies give strong evidence to the evagination model of disc formation where new discs develop as evaginations of the ciliary plasma membrane and successive evaginations fuse to form the discrete discs [6] [7] [8] . The tips of outer segments, which contain the oldest discs and associated proteins, are recognized, phagocytosed, and digested diurnally by the neighboring retinal pigment epithelium (RPE) 9, 10 . ROS renewal is regulated, in part, by light as demonstrated by reports that exposure to light inhibits delivery of Rhodopsin to the ROS 11 and that the shedding event is initiated by illumination 12, 13 . In addition, phosphodiesterase inhibitors can mimic the dark state to prevent ROS shedding 14 . Beyond this, our understanding of the mechanisms that regulate renewal are limited. Stress from insults to the system, such as mutations in the protein
Results
High content screen of 1351 bioactive compounds on ROS renewal. ROS renewal occurs only in the intact retina, and efforts to recapitulate the process by culturing rods have been unsuccessful 22 . The zebrafish offers several unique advantages as an in vivo model for ROS renewal studies, including the amenability for compound screening. The zebrafish retina develops rapidly with large numbers of ROS present as early as 5 days post fertilization (dpf) 23 . It is easy to generate the large numbers of individual animals needed for a bioactive compound screen, and compounds can be delivered by bathing the zebrafish in small volumes of water that require small amounts of compound. Finally, the Tg(hsp70:HA-mCherry TM ) line provides a quicker method for measuring ROS renewal kinetics than the time-consuming and cumbersome autoradiography, which relies on detection of radioactively-labeled proteins and has been rarely used since the 1970s 4, 5, 20 .
To identify potential pathways that regulate ROS renewal, we tested 1351 compounds with known bioactivity. Figure 1 describes the screening approach. At 6 dpf, Tg(hsp70:HA-mCherry TM ); Tg(Xla.rho:EGFP); alb −/− fish were heat shocked to induce expression of the HA-mCherry TM marker of ROS renewal (mCherry TM stripe) and then immediately transferred to tissue culture wells containing 20 μM of compound or 0.2% DMSO (vehicle control). At 10 dpf (4 days post heat shock), fish were fixed and processed for immunofluorescence (Fig. 1a) . Antibodies against GFP and the HA-epitope in the mCherry TM stripe were used to extend the lifetime and enhance the fluorescence of these proteins; antibody against Rhodopsin was used to label the ROS and reveal possible effects on Rhodopsin localization. Confocal z-stacks of the photoreceptor layer and of the peripheral rim of the retina, which includes the CMZ, were collected for image analysis (Fig. 1b) . The primary goal of the screen was to identify potential molecular pathways that regulate ROS renewal. ROS growth and shedding were measured within the 3-dimensional confocal z-stacks as the distance from the base of the ROS to the mCherry TM stripe (D G ) and the distance from the mCherry TM stripe to the tip of the ROS (D S ), respectively (Fig. 1c) . To expand the utility of the screen, we also qualitatively examined the photoreceptor layer and CMZ for 3 other content areas: the accumulation of phagosomes as an indication of disrupted function of the retinal pigmented epithelium (RPE) to phagocytose and/or digest shed ROS material (Fig. 1d) , Rhodopsin mislocalization as an indication of disrupted trafficking (Fig. 1e) , and shape of the peripheral rim and CMZ for disrupted addition of new rods (Fig. 1f) . See Materials and Methods for details on the screen design, data collection, and analysis. The complete list of the screened compounds, of which approximately 30% were lethal at the tested concentration, and resulting data are provided in Supplementary Table S1. ROS growth is disrupted by bioactive compound treatment. D G represents the ROS growth that occurred after heat shock and during the 4 days of compound treatment (Fig. 2a) . D G can be highly variable between independent experiments. This is attributable to variation between ROS within a retina as well as variation between individual fish from the same compound treatment. The variability is due to any combination of intrinsic and extrinsic variables that affects overall growth and development of the fish, such as egg quality, temperature, water quality, and the availability and quality of food at first-feeding 24 . In order to account for this variability, the ROS measurements from 3 fish treated with the same compound were combined and analyzed with mixed effects modeling to determine mean and standard deviation. Mean D G from compound-treated fish was compared to mean D G from DMSO control-treated fish that were fertilized within the same clutch and processed through the screen concurrently. Comparisons were made using the Dunnett comparison procedure 25 with the adjusted p-values from the mixed effects modeling.
In order to identify compounds of potential interest, we first determined a benchmark for D G by analyzing all of the DMSO control-treated fish that were processed during independent iterations of the screen (n = 213 fish with a total of 5,246 measured ROS). The mean D G for all DMSO controls was 5.01 μm (±0.650 μm) or 1.25 μm per day (Table 1) . This D G benchmark of 5.01 μm represented an expected average D G for the DMSO control but was not an appropriate value to compare with individual compound treatments due to the variability discussed above. Instead, the benchmark was used to set a threshold for changes in D G . A 1 μm difference in the benchmark D G during the 4 days post heat shock of the screen assay would represent a 20% change. Using this as a biological threshold, we focused initial attention on those compounds that increased D G by at least 20% as compared to the associated DMSO control and with statistical significance of p < 0.001. Upon identifying compounds of interest, we examined other compounds with the same target that similarly affected D G although perhaps outside of the biological (≥20%) and statistical (p < 0.001) thresholds.
We observed 67 compounds that increased D G by at least 20% as compared to the associated control, and 32 were statistically significant with p < 0.001. The signaling pathways most commonly targeted were involved in neuronal signaling, as well as DNA damage, metabolism, and endocrinology/hormones (Fig. 2b) . Several ; alb −/− fish were heat shocked at 6 dpf to induce expression of HA-mCherry TM followed by rearing in 20 μM compound until 10 dpf when tissues were fixed and processed for immunolabeling and confocal microscopy. We observed 140 compounds that decreased D G by at least 20% as compared to the associated DMSO control, and 108 were statistically significant with p < 0.001. The most common pathways targeted by these compounds were involved in mTOR, neuronal signaling, protein tyrosine kinase, cell cycle, endocrinology and hormone, and DNA damage pathways (Fig. 2d Supplementary Table S1 .
ROS shedding is disrupted by bioactive compound treatment. D S was determined by measuring the distance from the mCherry TM stripe to the ROS tip. This distance represents the ROS growth that occurred before heat shock minus any shedding during the 4-day compound treatment (Fig. 3a) . Again, D S is variable due to subtle experimental conditions and likely inherent biological determinants. Mixed effects modeling was used to analyze D S data, and D S for compound-treated fish was compared (with the Dunnett comparison procedure) to D S for the associated DMSO control-treated fish that were fertilized within the same clutch and processed through the screen concurrently.
In order to identify compounds of potential interest, a benchmark for D S was first determined by analyzing all DMSO control-treated fish from the study (n = 213 fish with a total of 4,223 measured ROS), which gave a mean D S of 3.40 μm ± 0.735 μm (Table 1) . Since the D S represents growth minus the amount shed, we had to account for the ROS growth that occurred prior to heat shock. In a previous study, ROS growth in untreated fish that were Inhibitors YO-01027 and LY411575 were screened during the same week and compared to the same DMSO control. Each ROS D S measurement is represented by a small dot of color that represents an individual fish (n = 24-105 rods from 3 fish). Lower and upper hinges of box plots correspond to first and third quartiles; middle line corresponds to median; whiskers extend 1.5 * interquartile range above and below the hinges; large single black dot represents the mean; small black dots represent outliers. ***p < 0.001; **p < 0.01, *p < 0.05 by Dunnett's comparison. reared in 14 h light/10 h dark cycle was 1.6 μm per day 14 . This best represented the rearing conditions of fish in this study prior to heat shock at 6 dpf. Therefore, assuming most rod births begin after 3 dpf We observed 63 compounds that increased D S by at least 20% as compared to the associated control, and 10 were statistically significant with p < 0.001. These compounds targeted pathways involved in neuronal signaling, cell cycle, metabolism, and MAPK signaling, among others (Fig. 3b) . Conversely, a decrease in D S indicates that shedding was increased or stimulated by compound treatment. We observed 188 compounds that decreased D S by at least 20% as compared to control, and 72 were statistically significant with p < 0.001. The pathways targeted by these compounds were involved in neuronal signaling, DNA damage, mTOR signaling, protein tyrosine kinase, endocrinology and hormone signaling, and protease pathways (Fig. 3d) . YO-01027 (D ) and 25% (p = 4.57 × 10
), respectively, as compared to the associated control ( Supplementary Table S1 .
Bioactive compounds inhibit RPE clearance of shed ROS material. Previous research has shown
that ROS shedding occurs shortly after the onset of light when the phagocytic RPE recognizes, engulfs, and digests the distal tips of the ROS 4, 9, 26 . When RPE phagocytic function is disrupted, retinal health and function are compromised. For example, failure to engulf shed ROS material, as in animal models lacking MerTK or both of its ligands Gas6 and Protein S, leads to perturbed disc morphology, build-up of debris between the outer segments and RPE, and rapid retinal degeneration 16, 19, 27 . In addition, loss of the rhythmic increase in phagocytosis after light onset, as in mice lacking the αvβ5 integrin or ligand MFG-E8, causes accumulation of inclusion bodies and age-related vision loss 28, 29 . Fluorescence microscopy with Rhodopsin immunolabeling has been used previously to identify Rhodopsin-positive phagosomes 29, 30 , and so the image analysis-based design of this screen allowed us to identify compounds that led to an accumulation of Rhodopsin-positive phagosomes distal to the ROS (Fig. 4a) .
We observed 73 compounds that resulted in phagosome accumulation. These compounds target pathways involved in neuronal signaling and mTor signaling (Fig. 4b) . Many compounds that target the mTor pathway led to a striking increase in phagosomes (Fig. 4c) . These compounds also decreased ROS growth (decreased D G ) and increased shedding (decreased D S ), suggesting that phagosome accumulation could be a consequence of increased ROS shedding, decreased RPE function, or both. Other compounds that increased phagosomes, including those that target MEK and adrenergic receptors did not increase ROS shedding, suggesting a direct effect on RPE function. The subset of data for compounds associated with phagosome accumulation is included in Supplementary Table S1 .
Bioactive compounds induce Rhodopsin mislocalization. Rhodopsin mislocalization, which is characteristic of many forms of retinitis pigmentosa, is thought to be a major contributing factor in photoreceptor cell death 31, 32 . The anti-Rhodopsin antibody used in this study normally labels Rhodopsin protein exclusively in the ROS. However, with some compounds we observed Rhodopsin mislocalization in the inner segment and cell body (Fig. 5a ). We observed 10 compounds that caused Rhodopsin mislocalization, including compounds that target mTor signaling and transmembrane transporters (Fig. 5b) . In the DMSO control, Rhodopsin was localized to the outer segments (Fig. 5c ). CYT387, a JAK1/2 inhibitor 33 , led to Rhodopsin accumulation in the inner segment, as well as some Rhodopsin puncta in the cell body (Fig. 5d) . Vinflunine, an inhibitor of microtubule assembly 34 , led to Rhodopsin mislocalization in both the inner segment and cell body (Fig. 5e) . Some of the compounds that led to Rhodopsin mislocalization, including the two mTor signaling inhibitors AZ20 and TIC10, also resulted in decreased D G . The subset of data for compounds associated with Rhodopsin mislocalization is included in Supplementary Table S1 .
Bioactive compounds disrupt development of new rods from the CMZ. The CMZ is a stem cell niche at the periphery of the zebrafish retina that continues to add new cells throughout the life of the fish 35, 36 . In the Tg(hsp70:HA-mCherry TM ) retina, only rods that were formed prior to heat shock exhibit the mCherry TM stripe. Therefore, we were able to qualitatively examine three regions of the peripheral rim of the retina: (1) the proliferative CMZ where there were no GFP-positive rods, (2) the region of newly formed rods that lacked the mCherry TM stripe because they developed after heat shock and during compound treatment, and (3) the region of older rods with mCherry TM stripes that developed before heat shock (Fig. 6a) . We observed 25 compounds that affected the CMZ (Fig. 6b) as compared to DMSO control (Fig. 6c) . Six of the compounds targeted proteases, all of which were γ-Secretase inhibitors. Cell cycle pathways, including four Aurora Kinase inhibitors, and protein tyrosine kinases were also targeted. Treatment with the IκB kinase 2 (IKK-2) inhibitor, TPCA-1 (categorized as pathway "NF-κB"), reduced the size of the proliferative zone and increased packing of new rods, which exhibited abnormal morphology (Fig. 6d) . Treatment with γ-Secretase inhibitors, DAPT and MK-0752 37 , caused a reduction in the proliferative zone and crowding of the new rods (Fig. 6e) . A nearly complete loss of the proliferative zone was observed with Aurora Kinase inhibitors, Alisertib and CCT129202 38, 39 (Fig. 6f) . A similar loss of the proliferative zone was observed with the topoisomerase inhibitor Irinotecan and its active metabolite SN-38 40 (Fig. 6g) . The subset of data for compounds associated with disrupted CMZ is included in Supplementary  Table S1 .
Discussion
Methodological limitations have delayed progress towards understanding the molecular mechanisms that regulate photoreceptor outer segment renewal. The recently developed transgenic (hsp70:HA-mCherry TM ) zebrafish expresses a marker of ROS renewal, which permits independent analysis of growth and shedding 20 . The transgenic mCherry TM stripe measurement tool combined with a small molecule screening approach provide a non-biased method to rapidly identify candidate molecular pathways. This approach has identified several candidate molecular pathways that regulate ROS renewal, as well as RPE phagocytosis, Rhodopsin mislocalization, and development of new rods at the CMZ. We were also attentive to potential effects on the integrity of the mCherry TM stripe as an indication of abnormal disc formation but did not observe any such qualitative changes. In order to screen as many compounds as possible, we limited the study to a single concentration over a single time course during larval ages. Additionally, given the workload of this screen, we were limited to processing a small number of fish for each compound (n = 3 unless otherwise noted in the Supplementary Table S1 ). However, the total number of ROS measured for each compound treatment was substantial and, in combination with two other factors in the analysis (1, setting a threshold for percent difference as compared to control, and 2, redundancy in molecular and pathway targets of the compounds tested), aided in identifying compounds of interest as modulators of ROS renewal. Thresholds for the increase and decrease of D G and D S were set at 20% difference as compared to the associated DMSO control. Benchmark values for D G and D S within this study were determined based on the analysis of all ROS measurements from DMSO control-treated fish (n = 213), while the threshold of 20% was somewhat arbitrarily selected. Nonetheless, with the complete analysis available in the Supplementary Table S1 , the lists of compounds of interest can be adjusted based on higher or lower thresholds. Despite the threshold value, a benefit of the small molecule screen is the redundancy of molecules and pathways targeted by different compounds. The role of some targets, such as cyclooxygenases in ROS growth, γ-Secretases in ROS shedding, and mTor signaling in phagosome clearance, is strongly supported since multiple compounds that target the same protein or pathway exhibit similar effects on the rod photoreceptors. From the results of this screen, a subset of compounds that affect ROS renewal similarly, including those that do so beyond the threshold of 20% difference and those that do not hit the threshold but target the same molecule or pathway, can be retested with a variety of concentrations, with fish at different ages, and for different lengths of time. For example, we recently expanded a study on the effects of PDE 5/6 inhibitors on ROS shedding with dose response curves and in adult fish. One of those compounds, Vardenafil, increased D S by 21%, while Sildenafil increased D S by 14% as compared to control when tested at 20 μM within this screen. In extended study both Vardenafil and Sildenafil maximally increase D S in larval and adult fish at the slightly higher concentration of 50 μM
14
. Zebrafish are particularly amenable to small molecule screening in part because they can be bathed in water with a small amount of compound. Consequently, the entire animal is affected by the compound, and small molecule screening provides the added benefit of targeting both rod cell autonomous and non-cell autonomous pathways 41 . Although new membranous discs are added to the base of the ROS by rod cell autonomous protein synthesis and trafficking 15 , it is unclear how neighboring cells, such as Müller glia and RPE, contribute to the regulation of ROS growth. ROS shedding is, in part, regulated by phototransduction and ROS phosphodiesterase 6 activity 14 but also requires non-cell autonomous regulation from the RPE 19, 42 . Further experimentation will be required to determine which cell types are directly affected by each compound. Future approaches to study candidate pathways will need to rely on gene manipulations including knock-out and overexpression studies. The generation of conditional and inducible gene expression and knock-out systems, like the TetOn system, will aid in addressing the cell-specific roles of candidate genes 43 .
The distance between the base of the outer segment and the mCherry TM stripe (D G ) represents ROS growth that occurred during incubation with the compound. Several compounds that inhibit cyclooxygenases (COX), which are key regulators of inflammation, increased ROS growth. Although it has been shown that mouse rod photoreceptors express COX-2 44 , it remains to be determined whether the growth-promoting effect observed in this study is through direct inhibition of cyclooxygenases in rods. The RPE is also a potential target of these inhibitors as it has been shown that cultured rat RPE expresses COX-1 constitutively while COX-2 expression increases upon incubation with isolated ROSs 45 . Another pathway mediating inflammation, among other roles, is the angiotensin system, also known as the renin-angiotensin-aldosterone system (RAAS). We observed that several inhibitors of this pathway, specifically competitive antagonists of the angiotensin II type I (AT1) receptor 46 , also increased ROS growth. It does not appear that photoreceptors express AT1, at least not in rat 47 , however human and rat RPE do express AT1 47, 48 . Nearly three times as many compounds decreased ROS growth compared to those that increased growth. This was not surprising since we have observed that food deprivation during this larval period decreases ROS growth (AMJ, unpublished observation). Furthermore, the high energy consumption of photoreceptors for daily protein and membrane synthesis 49 suggests that any compound that compromises the ability of the larva to ingest and metabolize their food or compromises overall larval growth will stunt ROS growth. We observed that many compounds affecting neuronal signaling pathways reduced ROS growth, predominantly those affecting serotonin signaling and glutamatergic signaling. These compounds may stunt ROS growth by altering feeding behavior or, in the case of serotonin signaling, disrupting gut function 50 . Similarly, compounds targeting the PI3K/Akt/mTor pathway, which also decreased ROS growth, may act systemically to reduce larval growth and secondarily reduce ROS growth. However as a central regulator of cell size 51 , these compounds may directly target rod cell growth by inhibiting the high metabolic rate these cells demand for daily maintenance.
ROS shedding distance (D S ), measured as the distance between the mCherry TM stripe and the ROS tip, represents growth that occurred before compound treatment minus any shedding that occurred during compound treatment. Therefore, a difference in D S between DMSO-treated fish and compound-treated fish reflects a change in the rate of ROS shedding resulting from compound treatment. We observed few compounds that significantly suppressed shedding (i.e., increased D S ). Four compounds that target cell cycle pathways, including inhibitors of CDK, Wee1, and Aurora Kinase, increased D S . Given that rods are post-mitotic, it seems unlikely that these compounds act directly as cell-cycle inhibitors on rods to increase D S . Although CCT129202 is a potent inhibitor of Aurora kinase 39 , it has also been shown to inhibit ABC transporters 52 . Whether CCT129202 inhibits the photoreceptor outer segment-specific ABC transporter, ABCA4 Nearly three times as many compounds increased ROS shedding (i.e., decreased D S ) as compared to decreased shedding. The pathways most commonly targeted by compounds that increased shedding are similar to those that decreased ROS growth, including neuronal signaling, PI3K/Akt/mTor, and DNA damage. As discussed above with decreased ROS growth, the high energy demands of photoreceptors make them particularly susceptible to the compounds that compromise overall metabolism in the larva. Decrease in both D G and D S by these compounds suggests that maintenance of ROS length is metabolically demanding for the regulation of shedding as well as the maintenance of ROS growth. Several compounds that inhibit γ-Secretase increased shedding (decreased D S ), and two of those (YO-01027 and LY11575) also decreased ROS growth. γ-Secretase expression in RPE maintains barrier function by mediating pigment epithelium-derived factor through processing of vascular endothelial growth factor 56, 57 . In addition, several compounds that inhibit Aurora Kinase decreased D S , and inhibition of Aurora Kinase has been associated with ciliary axoneme stabilization in a RPE cell line 58 . Therefore, γ-Secretase and Aurora Kinase inhibitors acting locally within the retina may be regulating ROS shedding by disrupting RPE function.
Several compounds that target the PI3K/Akt/mTor pathway led to an increase in anti-Rhodopsin-labeled phagosomes as well as an increase in shedding (decreased D S ). Increased shedding (decreased D S ) is not always associated with increased phagosomes, suggesting that the phagocytic RPE is usually capable of clearing and digesting excess shed ROS material. Therefore, the increase in phagosomes with inhibition of the PI3K/Akt/mTor pathway may be due to direct effects on RPE function. Indeed, an analysis of RPE gene expression in the RCS rat (lacking mertk function) revealed early changes in the mTOR pathway 59 . Alternatively, several compounds that affect adrenergic signaling caused an increase in phagosomes (four α adrenergic receptor agonists and one α adrenergic receptor antagonist) without affecting D S . With α-adrenergic receptor expression reported in the RPE 60, 61 , it is possible that these compounds act directly on RPE to modulate phagocytic activity. Based on our current understanding of RPE phagocytic activity, the compounds that result in phagosome accumulation could be (1) inhibiting complete engulfment of shed outer segments similar to the MerTK deficiency in the RCS rat 16, 19, 27 , (2) disrupting the synchronicity of phagocytosis after light onset as in mice lacking the αvβ5 integrin or ligand MFG-E8 28, 29 , (3) delaying phagosome trafficking from the apical to the basal regions of RPE as in mice lacking the actin-associated proteins myosin VIIa or annexin A2 62, 63 , or (4) delaying digestion of phagosomes as in mice lacking melanoregulin 64 . Although many proteins and pathways have been identified that contribute to Rhodopsin trafficking and transport, such as small GTPases and the IFT complex 65, 66 , we still lack a full understanding of the processes that regulate Rhodopsin trafficking and localization. In this study, relatively few compounds resulted in Rhodopsin mislocalization, which may be because the pathways that regulate Rhodopsin trafficking and localization are essential for larval viability 67 . Many of the compounds that did cause Rhodopsin mislocalization were associated with degenerating rods, and in most cases the mislocalization was observed in only some rods. Furthermore, we observed no Rhodopsin mislocalization with most of the compounds that caused ROS degeneration, suggesting that Rhodopsin mislocalization does not simply result from degeneration. This is consistent with observations that while Rhodopsin mislocalization has been observed in some mouse rod degeneration mutants (e. g., rds/rom1 68 and tulp1 69 ), Rhodopsin mislocalization is not associated with degeneration in other mutants (e. g., mertk 70 , rpe65, lrat 71 , and cngb1
72
). Sustained growth of the zebrafish retina allowed us to screen for compounds that disrupted the proliferative zone and morphology of newly-formed rods at the CMZ. Most commonly, we identified compounds that target Notch signaling and cell cycle pathways, consistent with previous molecular characterization of the CMZ 35 . Both γ-Secretase and IKK/NF-kB are important components of Notch signaling 73 , and compounds that inhibit these proteins reduced the size of the proliferative zone and appeared to increase the number of newly formed rods, as reflected by abnormal rod density and disrupted morphology. Not surprisingly, compounds that target cell proliferation, either directly by targeting the cell cycle or indirectly by targeting DNA damage pathways, caused a qualitative reduction in the proliferative zone of the CMZ. A major limitation with this content area is the low n used to assess the CMZ. Despite this, the data are a useful report for identifying compounds and targets for further analysis.
A greater understanding of the molecular mechanisms that regulate ROS renewal will guide treatment and interventions for retinal degeneration diseases. Current hurdles in treating these diseases include a lack of druggable targets and crossing the blood-retinal barrier 74 . This screen assists in addressing the first hurdle of identifying candidate pathways as targets with the benefit that many of the compounds are FDA approved, which would expedite their use in therapeutic treatment. Furthermore, recent progress using a nanosized liposomal drug delivery system may facilitate the transport of potential therapeutic compounds across the blood-retinal barrier 74 . Prior to therapeutic intervention, however, further investigation with cell-autonomy centered experiments will be required to identify the cell types directly targeted by the compounds. To this end, we have created TetOn-based tools to manipulate gene expression in rod photoreceptors 43 as well as in RPE (Jensen and Willoughby, unpublished). These cell-type specific TetOn tools and CRISPR/Cas9 approaches used along with the Tg(hsp70:HA-mCherry TM ) tool provide the opportunity to make rapid progress in expanding our understanding of photoreceptor outer segment renewal and may illuminate therapeutic targets to slow or prevent the degeneration of outer segments, which is associated with, and possibly causal to, photoreceptor degeneration in disease.
Materials and Methods
Zebrafish care and maintenance. This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the University of Massachusetts Amherst Institutional Animal Care and Use Committee. All fish lines were maintained according to standard methods 75 at 28 °C on a 14/10-hour light/dark cycle. All fish lines were a mixed AB/albino b4/b4 background 76, 77 . Pre-screen embryo and larva maintenance. Embryos were collected from mass matings, pooled together, and sorted into petri dishes at a density of 100 embryos per dish with egg water (0.3 g/L Instant Ocean Sea Salt; Spectrum Brands, Blacksburg, VA, USA). Embryos were maintained at 28-30 °C in a benchtop incubator until 6 dpf. At 5 dpf, fish were screened for GFP fluorescence in the retina and maintained in 5 ppt salt water (Instant Ocean Sea Salt; Spectrum Brands) with live rotifers at 1,000 rotifers/mL 78 .
Heat shock and compound treatment. Transmembrane-associated mCherry (HA-mCherry TM ) expression was induced at 6 dpf, 4 hours after the onset of light by incubation in 38 °C water for 45 minutes. After heat shock, fish were distributed into wells of 12-well tissue culture plates at 8 fish per well in 3 mL room temperature 5 ppt salt water (Instant Ocean Sea Salt; Spectrum Brands, Blacksburg, VA, USA) containing 20 μM bioactive compound (10 mM stock in DMSO, Bioactive Compound Library L1700, Selleck Chemicals, Houston, TX, USA) or 0.2% DMSO plus 1,000 rotifers/mL. Compounds were screened on a weekly basis at 8 to 32 compounds per week. In addition, DMSO vehicle control was processed each week so that compound-treated fish could be compared to control fish with as many environmental factors controlled for as possible (e. g., clutch, rotifer batch, temperature, water, etc.) Plates containing the control and compound-treated fish were maintained under standard fish facility conditions (28 °C on a 14/10-hour light/dark cycle) for 4 days and were examined daily. Water/compound was not exchanged. Dead fish were removed, and the number of rotifers remaining was monitored. At 1 day post heat shock, additional rotifers were not needed. Additional rotifers were added at 150-200 μL of 1,000 rotifers/mL on 2 days post heat shock to the DMSO control well and all other wells such that the number of rotifers present in each well, as monitored by eye, was similar to the DMSO control well levels. At 3 days post heat shock, rotifer numbers were similarly monitored and added as needed.
Tissue Processing and Immunofluorescence. Fish were fixed at 10 dpf, 4 hours after the onset of light in 4% paraformaldehyde for 1 hr at room temperature. Fish were briefly washed in PBS and tails were removed. Heads were embedded in 1.5% agar/5% sucrose and equilibrated in 30% sucrose. Embedded tissues were sectioned at 30 μm thickness with a Leica cryostat. Tissue sections were rehydrated with PBS containing 0.1% Tween Image collection and analysis. Images were generated as z-stacks of optical sections using a Zeiss LSM 700 Confocal system with a 40 × /1.4 NA oil objective and processed with Zen software (Carl Zeiss, Thornhill, NY, USA) and Adobe Photoshop (San Jose, CA, USA). The photoreceptor layer from the central retina was imaged from three different individuals (unless otherwise noted in the Supplementary Table S1 ) and a single representative CMZ image was collected from one individual within the treatment group. Z-stacks were collected with a thickness of 24-28 μm with step size of 0.426 μm. Representative images are maximum intensity z-projections.
The Zeiss z-stack files (.lsm) were imported into Volocity 3D Image Analysis Software (PerkinElmer, Waltham, MA, USA), which accounts for distance between z-sections and allows for measurements to be made within the three-dimensional z-stack. Measurement analyses were performed using the line function by manually drawing from the base of the outer segment to the middle of the mCherry TM stripe for D G and from the middle of the mCherry TM stripe to the tip of the outer segment for D S . The base and tip of the outer segments were determined by the Rhodopsin staining and morphology as indicated with the Xop:eGFP fluorescence. All ROS within an image were measured where the mCherry TM stripe was present and the ROS base/tip were visible. Intensity of the fluorescence channels were adjusted with the Volocity software as needed per image to identify these landmarks. Confocal images were saved with coded file names according to week number and sample number such that the individuals who performed the measurement analysis did not know the compound identity.
For the qualitative content areas, z-stacks for the three outer segment layer images and the single CMZ image for each compound and control were converted to maximum intensity z-projections in the Zen Software (Carl Zeiss, Thornhill, NY, USA) and imported into Volocity 3D Image Analysis Software (PerkinElmer, Waltham, MA, USA). Each image for every compound and control was viewed and assessed in the far red channel for the presence of phagosome accumulation as determined by packets of positive anti-Rhodopsin immunofluorescence in the subretinal space distal to the ROS (Fig. 4) . A compound of interest was determined if at least one of the three images showed accumulation of phagosomes. Similarly, the far red channel was assessed, independent of the green and red channels, for the presence of Rhodopsin immunofluorescence in rod cell bodies for the Rhodopsin mislocalization content area (Fig. 5) . A compound of interest was determined if at least one of the three images showed Rhodopsin mislocalization. To identify the proliferative zone in the CMZ image (Fig. 6) , brightness in the red channel was greatly increased in Adobe Photoshop (San Jose, CA, USA), the margin was traced with a dotted line, and then the red channel brightness was returned to original level.
SCientifiC REPORTs | (2018) 8:14017 | DOI:10.1038/s41598-018-32336-y Statistics and quantification of outer segment renewal. Data were plotted using the ggplot2 package 80 in R (version 3.2.3) 81 . Box plots represent the distribution of data with lower and upper hinges of the box corresponding to first and third quartiles and middle bar corresponding to the median. Whiskers extend 1.5 * interquartile range above and below the hinges; dots represent outliers. Large black dot represents the mean; small colored dots represent individual measurements with color corresponding to individual fish.
To analyze the D G and D S measurements, the data for each week of the screen were fit with mixed effects modeling using the lmerTest package in R 82 . Mean, standard deviation, and the total number of measured ROS for each compound and DMSO control were determined and compiled (plyr package 83 , R). D G and D S means for a compound were compared to the control D G and D S means for the DMSO control that was processed during the same week using Dunnett's comparison with the adjusted p-values from the mixed effects modeling (multcomp package 84 , R). Significance levels are ***(p < 0.001), **(p < 0.01), and *(p < 0.05). Qualitative data were combined with measurement data, and then all data were sorted in Microsoft Excel (Redmond, WA, USA) according to content areas.
